Vascular cognitive impairment often goes undetected until significant damage has occurred — partly because clinicians lack agreed-upon diagnostic standards. A rigorous real-world validation of newly released criteria could change how early-stage cerebrovascular disease is identified and acted upon in otherwise healthy-appearing older adults, potentially opening a window for intervention before frank dementia sets in.
Using data from the I-Lan Longitudinal Aging Study, investigators applied the freshly minted VasCog-2-WSO criteria — developed jointly by the VasCog Society and the World Stroke Organization — to 1,236 community-dwelling adults aged 50 and older who had no prior stroke or dementia diagnosis. Participants underwent standardized brain MRI and comprehensive neuropsychological testing. The neuroimaging-first classification system identified cerebrovascular disease markers in nearly one in five participants (19.6%), with 19.2% meeting the threshold for preclinical VCID and a small fraction (0.4%) qualifying as vascular mild cognitive impairment. Baseline cardiovascular risk was quantified via the 10-year Framingham score, and all-cause mortality was tracked over a mean follow-up of 9.4 years using Cox and Poisson regression models.
The significance here extends beyond diagnostic taxonomy. By anchoring VCID classification to neuroimaging biomarkers rather than relying solely on clinical symptoms, the VasCog-2-WSO framework catches a substantial burden of subclinical cerebrovascular pathology that conventional assessment would miss. The near-20% preclinical prevalence in a stroke-free, dementia-free cohort is striking — it suggests vascular brain injury is quietly accumulating across a broad population slice long before cognitive complaints emerge. The mortality association, if confirmed across diverse cohorts, elevates these criteria from an academic classification exercise to a clinically consequential prognostic tool. Key limitations include the single-site, predominantly Taiwanese sample, which may limit generalizability, and the observational design, which precludes causal inference. Still, the longitudinal depth (nearly a decade of follow-up) and the rigorous neuroimaging protocol make this a meaningfully confirmatory — and potentially practice-shaping — contribution to the vascular dementia field.